A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult Participants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT05217641

Recruitment Status : Active, not recruiting

First Posted : February 1, 2022

Last Update Posted : January 11, 2024

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborators:

National Institutes of Health (NIH)

Department of Health and Human Services

Information provided by (Responsible Party):

National Institute of Allergy and Infectious Diseases (NIAID)

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Actual Primary Completion Date :	July 17, 2023
Estimated Study Completion Date :	June 24, 2027

To Top